Published in JAMA on August 13, 2014
NORCCAP: Norwegian Colorectal Cancer Prevention Trial | NCT00119912
Percentage Visualized Mucosa as a Marker for the Quality of Colonoscopy | NCT04482452
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet (2015) 7.50
Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials. BMJ (2015) 1.43
Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ (2017) 1.38
Colorectal cancer and the effect of flexible sigmoidoscopy screening. JAMA (2014) 1.10
Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol (2016) 1.09
Nutrients, foods, and colorectal cancer prevention. Gastroenterology (2015) 1.04
Reducing inequities in colorectal cancer screening in North America. J Carcinog (2014) 1.00
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci (2015) 0.96
Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med (2016) 0.96
Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials. Clin Trials (2016) 0.93
The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients. J Gen Intern Med (2015) 0.92
Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study. Ann Intern Med (2016) 0.87
Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy (2016) 0.84
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer (2015) 0.81
Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol (2015) 0.81
Diagnostics and Epidemiology of Colorectal Cancer. Visc Med (2016) 0.81
Bounding the per-protocol effect in randomized trials: an application to colorectal cancer screening. Trials (2015) 0.79
Flexible sigmoidoscopy for colorectal cancer screening: more evidence, persistent ironies. JAMA (2014) 0.79
Detection of Advanced Neoplasia with FIT Versus Flexible Sigmoidoscopy Versus Colonoscopy: More Is More. Dig Dis Sci (2015) 0.78
Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77
Do no harm: no psychological harm from colorectal cancer screening. Br J Cancer (2016) 0.77
Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol (2015) 0.76
Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer (2016) 0.76
Colorectal cancer screening: the time to act is now. BMC Med (2015) 0.76
Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study. Oncotarget (2016) 0.75
Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia. World J Gastroenterol (2016) 0.75
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol (2016) 0.75
Does a Pre-Training Program Influence Colonoscopy Proficiency during Fellowship? PLoS One (2016) 0.75
Psychological effects of colorectal cancer screening: Participants vs individuals not invited. World J Gastroenterol (2016) 0.75
Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget (2016) 0.75
Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clin Med Insights Pathol (2016) 0.75
Invitation for flexible sigmoidoscopy screening reduced colorectal cancer and colorectal cancer mortality. Ann Intern Med (2014) 0.75
What is the optimal colorectal cancer screening program for an average-risk population? Transl Gastroenterol Hepatol (2017) 0.75
Colorectal cancer screening. Singapore Med J (2017) 0.75
More Is Not Always Better: A Randomized Trial Of Low Volume Oral Laxative, Enemas, And Combination Of Both Demonstrate That Enemas Alone Are Most Efficacious For Preparation For Flexible Sigmoidoscopy. Clin Transl Gastroenterol (2016) 0.75
Principles of Cancer Screening. Surg Clin North Am (2015) 0.75
Colorectal cancer and the effect of flexible sigmoidoscopy screening--reply. JAMA (2014) 0.75
Should Screening Colonoscopy Be Offered From Age 50? Dtsch Arztebl Int (2017) 0.75
Colonoscopy in Colorectal Cancer Screening: Current Aspects. Indian J Surg Oncol (2015) 0.75
Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality? Cancer (2017) 0.75
Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. Eur J Epidemiol (2017) 0.75
Colorectal cancer screening: An updated review of the available options. World J Gastroenterol (2017) 0.75
Flexible sigmoidoscopy: more than a unilateral breast exam? Dig Dis Sci (2015) 0.75
Quality Indicators in Colonoscopy. Curr Treat Options Gastroenterol (2017) 0.75
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
The evolution of cancer of the colon and rectum. Cancer (1975) 9.05
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med (2001) 8.76
Instruments for causal inference: an epidemiologist's dream? Epidemiology (2006) 8.50
Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med (2000) 6.90
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer (2008) 5.00
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75
Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. J Natl Cancer Inst (2002) 3.00
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol (2010) 2.26
Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol (2003) 1.87
Causal inference from longitudinal studies with baseline randomization. Int J Biostat (2008) 1.69
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol (2002) 1.68
Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study. J Clin Epidemiol (1999) 1.55
Colorectal cancer screening in Europe. World J Gastroenterol (2009) 1.47
The Norwegian guidelines for surveillance after polypectomy: 10-year intervals. Scand J Gastroenterol (1996) 1.15
Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scand J Gastroenterol (2012) 1.11
Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome. Int J Colorectal Dis (2009) 1.01
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. Oncotarget (2016) 0.80
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study. PLoS One (2014) 0.75